Gian Life Care Peer Comparison

Snapshot Summary

Gian Life Care Ltd. shows strong profitability metrics despite a significant decline in revenue growth, placing it among the more financially stable options in a sector filled with high valuations. However, its substantial revenue drop raises concerns about future growth prospects. Overall, while Gian Life Care has appealing valuation metrics, other peers demonstrate better growth trajectories, with a few being significantly overpriced.

• Gian Life Care Ltd. has a low PE ratio of 5.31, making it undervalued relative to peers.
• Despite a sharp revenue decline of -49.46% YoY, Gian Life Care maintains a high ROE of 24.15%, indicating strong profitability.
• Max Healthcare and Fortis Healthcare are identified as financially weak due to their high PE ratios and low profitability margins.

• Narayana Hrudayalaya Ltd.: Strong ROE of 24.27% and solid EPS growth, showcasing both profitability and growth potential.
• Max Healthcare Institute Ltd.: Highest revenue growth YoY at 18.49% and consistent EPS growth, indicating a robust growth trajectory.
• Apollo Hospitals Enterprise Ltd.: Well-rounded metrics with a good balance of revenue growth and profitability.

Stock	CMP	Market Cap	P/E	ROE (%)	ROCE (%)	Debt/Equity
Gian Life Care Ltd.	₹12.20	₹12.62Cr	-168.28	24.15%	28.68%	0.25
APOLLOHOSP	₹7,824.50	₹1,12,510.06Cr	71.50	20.51%	21.19%	0.67
MAXHEALTH	₹1,145.90	₹1,11,466.91Cr	97.13	13.47%	16.26%	0.14
FORTIS	₹1,030.70	₹77,269.97Cr	88.97	9.77%	12.14%	0.25
NH	₹1,785.00	₹36,492.71Cr	46.46	24.27%	21.62%	0.61
ASTERDM	₹678.45	₹35,159.69Cr	110.51	9.32%	11.46%	0.19
MEDANTA	₹1,274.60	₹34,290.93Cr	64.20	15.31%	20.50%	0.10

Explore

Watchlists

Command Palette

Gian Life Care Peer Comparison

Snapshot Summary